BIOQUAL, Inc.
BIOQ
$38.51
-$1.49-3.73%
OTC PK
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.86M | 11.67M | 14.03M | 11.40M | 11.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.86M | 11.67M | 14.03M | 11.40M | 11.77M |
| Cost of Revenue | 8.98M | 5.59M | 11.30M | 11.51M | 11.33M |
| Gross Profit | 875.60K | 6.08M | 2.73M | -113.60K | 437.30K |
| SG&A Expenses | 1.39M | 6.20M | 1.56M | 1.71M | 1.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.37M | 11.79M | 12.86M | 13.22M | 12.90M |
| Operating Income | -518.80K | -118.20K | 1.17M | -1.82M | -1.13M |
| Income Before Tax | -343.40K | 26.30K | 1.29M | -1.67M | -931.80K |
| Income Tax Expenses | -94.60K | 123.00K | 355.30K | -460.20K | -256.50K |
| Earnings from Continuing Operations | -248.80K | -96.70K | 936.00K | -1.21M | -675.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -248.80K | -96.70K | 936.00K | -1.21M | -675.30K |
| EBIT | -518.80K | -118.20K | 1.17M | -1.82M | -1.13M |
| EBITDA | 47.50K | 447.60K | 1.77M | -1.23M | -512.10K |
| EPS Basic | -0.28 | -0.11 | 1.05 | -1.36 | -0.76 |
| Normalized Basic EPS | -0.24 | 0.02 | 0.90 | -1.17 | -0.65 |
| EPS Diluted | -0.28 | -0.11 | 1.05 | -1.36 | -0.76 |
| Normalized Diluted EPS | -0.24 | 0.02 | 0.90 | -1.17 | -0.65 |
| Average Basic Shares Outstanding | 894.40K | 894.40K | 894.40K | 894.40K | 894.40K |
| Average Diluted Shares Outstanding | 894.40K | 894.40K | 894.40K | 894.40K | 894.40K |
| Dividend Per Share | -- | 0.50 | -- | -- | -- |
| Payout Ratio | -- | 0.00% | 0.00% | -36.89% | -- |